Esophageal cAncer Screening Trial

CompletedOBSERVATIONAL
Enrollment

14,597

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Esophageal Squamous Cell CarcinomaEsophageal CancerGastroesophageal Junction Adenocarcinoma
Interventions
DIAGNOSTIC_TEST

Sponge cytological test

Esophageal cell specimen were collected with Esoheal 1.0 sponge collection device. A prediction model will be built based on digital cytopathological features of participants.

Trial Locations (1)

200433

Changhai Hospital, Shanghai

All Listed Sponsors
collaborator

Shanghai Municipal Science and Technology Commission

OTHER_GOV

lead

Changhai Hospital

OTHER

NCT04609813 - Esophageal cAncer Screening Trial | Biotech Hunter | Biotech Hunter